This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Shares lost a quarter of their value after the company disclosed, in a regulator...
The funding was meant to help the U.S. prepare for pandemics triggered by avian ...
A therapy at the center of their $22 billion alliance failed to extend survival ...
The company is preparing a Phase 3 trial of enobosarm with a novel formulation t...
Commissioner Martin Makary and two of his deputies aim to meet with drugmaker CE...
Weeks after shelving a TIGIT drug prospect, the biotech is seeking to sell off i...
The British drugmaker may have succeeded in reviving an oral antibiotic previous...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped ...
The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting io...
The agency recommends manufacturers update their vaccines to target the JN.1 str...
The startup is the latest beneficiary of investors’ appetite for protein-degradi...
City will receive $46 million from Biogen under the alliance. Elsewhere, Angelin...
The FDA has placed a clinical hold on the study while Rocket works with trial mo...
Integrated informatics platforms boost R&D speed, data quality and ROI across Bi...
The demand for fill/finish services has never been greater, how are CDMOs respon...
The advisory committee, which met after the agency rolled out new vaccine guidel...
Still, the therapies’ modest benefit as a maintenance therapy points to how bett...
Tumors with low- and ultra-low levels of a protein called HER2 are treatable wit...
Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the ...
Speaker Mike Johnson negotiated a number of last minute changes to the megabill ...
The Danish drugmaker unveiled a series of initiatives to increase access to Wego...
An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna i...
Founded in 2021, ReproNovo has licensed rights to two drugs from Mereo BioPharma...
The announcement, which followed the FDA setting new guidelines on COVID vaccine...